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ABSTRACT  
Background: Hysteroscopy is an efficient procedure of management in many gynecologic 
conditions. There are few published data on hysteroscopy and recurrent pregnancy loss especially in 
developing countries.  
Objectives: To assess hysteroscopic findings in patients with consecutive miscarriages, and to 
compare the prevalence of uterine abnormalities between women with two and three or more 
miscarriages. 
Methods: Three hundred and twenty four women with two or more consecutive miscarriages were 
enrolled in the study. All participants underwent a diagnostic hysteroscopy. Congenital (arcuate 
uterus, septate uterus, unicornuate uterus) and acquired uterine abnormalities (intrauterine 
adhesions, polyp and submucous myoma) were documented. The findings were compared between 
the groups of women with two miscarriages and women who had three or more miscarriages. 
Results: Out of a total of 324 women [their mean (SD) of the age and gravidity was 28.3 (6.5) years 
and 5.1(1.5), respectively] 135 (41.7%) and 189 (58.3%) had two consecutive miscarriages and 
three or more consecutive miscarriages, respectively. While 194 (59.9%) women had no 
pathological findings on hysteroscopy, 130 (40.1%) women were found to have uterine anomalies. 
The congenital anomalies were found in 79 (24.4%) and the acquired were in 51 (15.7%) women. 
In comparison with women who had three or more miscarriages, women who had two miscarriages 
had significantly higher number of congenital anomalies, 53/135 (39.2%) vs. 26/189 (13.8%), P < 
0.001.  However there was no significant difference in the acquired anomalies between women who 
had two miscarriages and women who had three or more miscarriages.  
Conclusions: Patients who had two consecutive miscarriages were found to have a higher 
prevalence of congenital anatomical abnormalities. Diagnostic hysteroscopy should be carried out 
after two such miscarriages. 
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ecurrent pregnancy loss (RPL) is 
traditionally defined as three or more 
spontaneous, consecutive pregnancy 
losses before completion of 20 weeks of 
gestation or the expulsion of a fetus weighing 
<500g1. Spontaneous miscarriage and RPL 
occur in 15% and1-2% of clinically diagnosed 
pregnancies in women of reproductive age, 
respectively2.  Several  factors  are  associated 
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with RPL such as embryonic/chromosomal 
abnormalities, maternal anatomic 
abnormalities (e.g. septate uterus), luteal 
phase defects, maternal autoimmune diseases, 
and antiphospholipid syndrome and to a lesser 
degree infection and hypercoagulable state3-5.  
However, there is an ongoing debate on 
possible causes of recurrent miscarriages as 
the exact pathophysiology and the majority of 
risk factors are not precisely described4. 
Congenital, or Mullerian anomalies such as 
septate, bicornuate, didelphic or unicornuate 
uterus were assumed to cause recurrent 
pregnancy complications such as late or 
recurrent early miscarriage, abnormal fetal 
presentation, intrauterine growth restriction 
and prematurity6,7.  Furthermore, a number of 
acquired uterine anomalies such as fibroids, 
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intrauterine adhesions and endometrial polyps 
were described with varying prevalence in 
patients with recurrent miscarriages, although 
their direct influence on miscarriages is not 
completely understood 8,9.  Likewise 
intrauterine adhesions (most often seen after 
sharp curettage) are associated with recurrent 
miscarriage 10, 11. 
Classically, a workup for a cause of RPL is 
recommended after three miscarriages.  
Recent findings do not necessarily support 
this traditional evaluation protocol 12,13.  The 
evaluation of healthy women after a single 
loss is not usually recommended, as this is a 
relatively common/sporadic event.  However, 
the risk of another pregnancy loss after two 
miscarriages is only slightly lower (24-29%) 
than that of women with three or more losses 
(31-33%) 14. Therefore, it is reasonable to 
start evaluating the case after two or more 
consecutive losses especially in elder women 
(> 35 years) or when the couples have 
difficulty in conceiving15. 
The aim of this study was to explore the 
hysteroscopic findings in patients with 
recurrent miscarriages. 
MATERIALS AND METHODS: 
A cross sectional study was conducted overa 
period of four years from July 2009 to June 
2013 at Obstetrics and Gynecology 
departments, Misurata Central Hospital, 
Misurata Oncology Centre and Iben-Sina 
Teaching hospital, Libya. Women with two or 
more consecutive miscarriages with 
pregnancy losses occurring during the first 20 
weeks of gestation were enrolled to the study.  
According to the criteria of Weiss et al., 
200516, a miscarriage was defined as: the 
spontaneous expulsion of a product of 
conception; the disappearance of fetal heart 
activity on ultrasound examinations; or failure 
of β-hCG to rise in serial measurements. 
There were no exclusion criteria such as 
karyotyping abnormalities or positive 
antiphospholipid antibodies. After signing an 
informed consent data were collected on 
patient's age, gravidity, parity and their 
outcomes and other investigative procedures 
already performed.  The exact gestational age 
at the time of miscarriage was recorded for 
each patient. Then the previous transvaginal 
ultrasound results were checked if a 
gestational sac, fetal shadow or heart activity 
was documented at any time prior to 
miscarriages.   
Hysteroscopy was performed under general 
anaesthesia in the proliferative phase of the 
menstrual cycle.  Cervical dilatation was 
performed (when necessary) to enable the 
insertion of the hysteroscope. Glycine 1.5% 
was used as distension medium.  Operative 
hysteroscopy was performed to remove the 
discovered anomalies. Hysteroscopic findings 
were documented. Laparoscopy was 
performed if needed e.g.to differentiate 
between complete septate and didelphic 
uterus or between partially septate and 
bicurnuate uterus. 
Statistics 
Data were entered and analyzed in a computer 
using SPSS for Windows. Chi square/Fisher's 
exact test was used for comparison of 
proportion.  P<0.05 was considered 
significant. 
RESULTS: 
Three hundred and twenty four women were 
enrolled in the study; their basic 
characteristics were shown in table1. Out of 
these 324 women, 135 (41.7%) and 189 
(58.3%) had two consecutive miscarriages 
and three or more consecutive miscarriages, 
respectively.  
Table (1): Basic characteristics of Libyan 
women with recurrent pregnancy loss women 
presented for hysteroscopy. 
Variable  Mean  ( SD) 
Age,  year 28.3(6.5) 
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21,16. These variations could be explained by 
the difference in study designs and the 
variations of anomalies reported in the 
respective studies 16.   
In the current analysis, women who had two 
miscarriages had significantly higher number 
of congenital anomalies, 53/135 (39.2%) vs. 
26/189 (13.8%), P < 0.001. Congenital uterine 
anomalies were previously reported in 17- 
25% of patients with recurrent 
miscarriages22,23. Since there was no 
exclusion criterion in this study, other causes 
of miscarriages were not analyzed and hence 
could not be excluded.  According to this 
result, patients who have suffered two 
miscarriages have more risk of congenital 
uterine pathology and equal risk of acquired 
pathology compared to those with three or 
more miscarriages. The role of arcuate uteri in 
the development of miscarriages is not that 
clear and may be controversial. However, the 
significance of other congenital anomalies for 
the development of pregnancy complications 
is well established 16, 24-26.  It was decided to 
include arcuate uteri in the current analysis as 
they are generally accepted and described as 
congenital anomalies in an established 
classification system (American Society of 
Reproductive Medicine, 1988). 
The question when to investigate recurrent 
pregnancy loss is also one of cost-benefit.  A 
workup investigation after two pregnancy 
losses will unnecessarily increase in the 
number of the investigated women.  Women 
with recurrent pregnancy loss generally have 
a good prognosis in their subsequent 
pregnancy.  After two miscarriages, 76% of 
patients can expect a successful subsequent 
pregnancy outcome 27 and therefore will not 
benefit from investigation.  These findings 
were contradicted by another study28, which 
found that the miscarriage rate increased 
substantially from 25 to 45% when comparing 
women with two or three previous 
miscarriages respectively.  Other researchers 
confirmed poor prognosis only when the 
number of subsequent pregnancy losses 
increased to four29 and six30 miscarriages. 
Diagnostic methods to assess the inner 
architecture of the uterus include transvaginal 
ultrasound, hysterosalpingography (HSG), 
and hysteroscopy.  It is generally accepted 
that hysteroscopy, possibly in combination 
with laparoscopy are the most accurate 
procedures in the diagnosis of congenital 
uterine anomalies 22.  Hysteroscopy is 
generally regarded to be essential when 
intrauterine pathology is suspected on 
transvaginal ultrasound, HSG 31.  However, 
even if no anomalies are found with the latter 
diagnostic tools, subtle intrauterine 
pathologies may be detected by hysteroscopy 
in 25-50% of patients 31,32.  Consequently, 
two-dimensional ultrasound and HSG are 
considered to be inadequate for diagnostic 
purpose as they are less accurate22.  A 
comparison of sonographic results with 
hysteroscopic findings was not the aim of the 
present study. Contrary to transvaginal 
ultrasound; hysteroscopy offers both a 
diagnostic and direct therapeutic approach of 
intrauterine congenital anomalies and 
acquired anomalies such as adhesions, 
fibroids and polyps.  A therapeutic septum 
dissection or adhesiolysis may improve the 
outcome in subsequent pregnancies33,34. 
CONCLUSION: 
Hysteroscopy is a simple and efficient tool in 
the early diagnosis and management of 
congenital and acquired uterine pathologies 
that might be causing recurrent pregnancy 
loss. Patients are advised to have it performed 
after two miscarriages. 
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